Research News and Research

RSS

ASU receives W. M. Keck $1 million grant to build next-generation 3D imaging microscope

The W. M. Keck Foundation has awarded Arizona State University a $1 million grant to the team of scientists led by Deirdre Meldrum, Ph.D., at the Biodesign Institute.

2 Mar 2011

Roundup: States' angst and anger continues about Medicaid, health spending cuts

Ken Kewley woke up Tuesday without health insurance for the first time in nearly nine years. So did most of the 41,467 other Pennsylvanians who had been covered by adultBasic, a state-subsidized insurance program for the working poor that Gov. Tom Corbett shut down on Monday in one of the largest disenrollments in recent memory.

2 Mar 2011

Scientists discover specific type of human cell to treat spinal cord injuries

For the first time, scientists discovered that a specific type of human cell, generated from stem cells and transplanted into spinal cord injured rats, provide tremendous benefit, not only repairing damage to the nervous system but helping the animals regain locomotor function as well.

2 Mar 2011

New PSA campaign to raise awareness about autoimmune diseases

The American Autoimmune Related Diseases Association Inc. has unveiled a multi-media public service/awareness campaign titled "We are 50 Million" to herald March 2011 as National Autoimmune Diseases Awareness Month.

2 Mar 2011

TOF positron emission tomography scans can improve cancer detection

For the first time, quantitative-not qualitative-data analysis has demonstrated that time-of-flight positron emission tomography scans can improve cancer detection.

2 Mar 2011

Study: Fluoride forms on teeth is up to 100 times thinner than previously believed

In a study that the authors describe as lending credence to the idiom, "by the skin of your teeth," scientists are reporting that the protective shield fluoride forms on teeth is up to 100 times thinner than previously believed.

2 Mar 2011

Study identifies key gene mutation responsible for type 2 diabetes in nearly 10% of patients

A multinational study has identified a key gene mutation responsible for type 2 diabetes in nearly 10 percent of patients of white European ancestry.

2 Mar 2011

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

The Translational Health Sciences and Technology Institute, an autonomous institute of the Indian government's Department of Biotechnology, and the International AIDS Vaccine Initiative announced today an agreement to jointly establish, operate and fund an HIV Vaccine Design Program in India.

2 Mar 2011

Common fungus might serve as therapeutic agent for plant and human health

Researchers have come closer to understanding how a common fungus "makes its living in the soil," which could lead to its possible "career change" as a therapeutic agent for plant and human health.

2 Mar 2011

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

Everyone knows someone that has been touched by cancer. Over one and a half million Americans will be diagnosed with some form of cancer in 2011, and more than 560,000 will die from the disease, accounting for 1 out of every 5 deaths.

2 Mar 2011

Researchers find mineral deficiency increases type 2 diabetes risk in African-Americans

Lower potassium levels in the blood may help explain why African-Americans are twice as likely to be diagnosed with type 2 diabetes as whites, according to a new study by Johns Hopkins researchers.

2 Mar 2011

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a marker for severe HCV-induced graft inflammation, as well as a predictor for unsuccessful treatment. Study findings—the largest to report on the role IL28B variants in a transplant cohort with recurrent HCV—are published in the March issue of Liver Transplantation, a journal of the American Association for the Study of Liver Diseases.

2 Mar 2011

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Oxygen Biotherapeutics, Inc. (NASDAQ and SIX Swiss Exchange: OXBT) today announced it has received a $2,075 million two-year grant from the U.S. Army to study the Company’s proprietary Oxycyte® PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury (TBI).

2 Mar 2011

Viruses that are natural part of human genome may retrovirus culprit

A retrovirus that inserted itself into the human genome thousands of years ago may be responsible for some cases of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gherig’s disease. The finding, made by Johns Hopkins scientists, may eventually give researchers a new way to attack this universally fatal condition.

2 Mar 2011

PreTreat Complete is now available for public to reduce migraine headaches

A new migraine supplement, PreTreat Complete, with active compounds designed to reduce the frequency and intensity of migraine headaches is now available.

2 Mar 2011

Achillion fourth quarter revenue is $2 million for three months ended December 31, 2010

Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and twelve months ended December 31, 2010.

2 Mar 2011

Cellastim and Optiferrin enable development of xeno-free and blood product-free expansion media

A recent study demonstrated that Cellastim and Optiferrin deliver superior xeno-free and animal-free solutions for primary cell and stem cell expansion media.

2 Mar 2011

Research: Blocking two cell DNA repair routes at once can provide new way to treat bowel cancer

Cancer Research UK-funded scientists have discovered that blocking two cell DNA repair routes at once could provide a completely new way to treat bowel cancer and potentially other cancers, according to research published in Cancer Research, today.

2 Mar 2011

Cord Blood America purchases all UCB samples and related lab equipment from RGI

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company, focused on bringing the life saving potential of cord blood stem cells to families nationwide and internationally, announced today that it has purchased all the umbilical cord blood samples and the related laboratory equipment from Reproductive Genetics Institute, Inc., based in Chicago, Illinois.

2 Mar 2011

Avvo launches new medical website for users to make physician search more effective

Avvo, the world's largest online directory for doctors and lawyers that provides free rankings for 90% of the working physicians in the U.S., continues to grow the number of service features offered on its medical website - to bring doctors and patients the latest, breakthrough online directory tools.

2 Mar 2011

Research News and Research

ASU receives W. M. Keck $1 million grant to build next-generation 3D imaging microscope

Roundup: States' angst and anger continues about Medicaid, health spending cuts

Scientists discover specific type of human cell to treat spinal cord injuries

New PSA campaign to raise awareness about autoimmune diseases

TOF positron emission tomography scans can improve cancer detection

Study: Fluoride forms on teeth is up to 100 times thinner than previously believed

Study identifies key gene mutation responsible for type 2 diabetes in nearly 10% of patients

IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India

Common fungus might serve as therapeutic agent for plant and human health

BigThink.com launches breakthroughs: Discussion highlighting cutting-edge cancer research

Researchers find mineral deficiency increases type 2 diabetes risk in African-Americans

Genetic variants determine severity of HCV-related graft disease and antiviral treatment response

Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte

Viruses that are natural part of human genome may retrovirus culprit

PreTreat Complete is now available for public to reduce migraine headaches

Achillion fourth quarter revenue is $2 million for three months ended December 31, 2010

Cellastim and Optiferrin enable development of xeno-free and blood product-free expansion media

Research: Blocking two cell DNA repair routes at once can provide new way to treat bowel cancer

Cord Blood America purchases all UCB samples and related lab equipment from RGI

Avvo launches new medical website for users to make physician search more effective

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest Life Science News